GABBR2 and Alzheimer disease: Here, our study reveals that the GABA receptor GABBR2, essential for the regulation of inhibitory synaptic transmission, was remarkably decreased in AD patients, negatively correlated with beta- and gamma-secretase activities, and displayed great diagnostic potential with AUC >0.8 in several datasets.